TMCnet News

Shares of Telik Rank the Lowest in Terms of Beta in the Biotechnology Industry (TELK, ROSG, PARD, QLTI, MAXY)
[February 03, 2013]

Shares of Telik Rank the Lowest in Terms of Beta in the Biotechnology Industry (TELK, ROSG, PARD, QLTI, MAXY)


Feb 03, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the lowest betas. Lower-beta stocks mean minimal volatility and are therefore generally considered to be a less risk and offer more stable returns.Telik ranks lowest with a a beta of 0.1. Rosetta Genomics is next with a a beta of 0.4. Poniard Pharmaceuticals ranks third lowest with a a beta of 0.5.



QLT follows with a a beta of 0.6, and Maxygen rounds out the bottom five with a a beta of 0.6.

SmarTrend recommended that its subscribers protect gains by selling shares of Maxygen on September 7th, 2012 by issuing a Downtrend alert when the shares were trading at $2.70. Since that call, shares of Maxygen have fallen 7.4%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.


Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To TMCnet.com's Homepage ]